# FDA 483 - UCLA Biomedical Cyclotron - July 31, 2025

Source: https://www.globalkeysolutions.net/records/483/ucla-biomedical-cyclotron/3eb814fe-3b8c-4da9-adfc-f9e4b47ec923

> FDA 483 for UCLA Biomedical Cyclotron on July 31, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: UCLA Biomedical Cyclotron
- Inspection Date: 2025-07-31
- Product Type: drugs
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of UCLA Biomedical Cyclotron in Los Angeles, a PET drug manufacturer, revealed significant deficiencies. The firm failed to approve processes before implementation, specifically regarding media fill simulations that did not reflect actual production. Additionally, the quality of microbiological media used in testing was not adequately controlled, and required testing on finished PET drug products was not performed before release.

## Related Documents

- [483 - 2020-07-31](https://www.globalkeysolutions.net/records/483/ucla-biomedical-cyclotron/65378da1-6811-4720-b6c1-047fa7d0879d)

## Related Officers

- [Kari C Dzulugbo](https://www.globalkeysolutions.net/people/kari-c-dzulugbo/c4a48588-68ba-490d-be66-0f3bd3b107ae)
- [Rowena S. Nguyen](https://www.globalkeysolutions.net/people/rowena-s-nguyen/ae39318e-1653-467c-94cc-26f8929441ac)
- [Youkeun Kim](https://www.globalkeysolutions.net/people/youkeun-kim/94ccfde4-72f7-4df1-9c68-ede73e5e23d0)
- [Pearl C. Ozuruigbo](https://www.globalkeysolutions.net/people/pearl-c-ozuruigbo/28ec383e-a602-4764-8d14-20b1049f93d7)

Company: https://www.globalkeysolutions.net/companies/ucla-biomedical-cyclotron/c81bfa21-90ca-4cbb-b13f-8158b4bcaa44

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b